Exchange Announcement • 20 Dec 2024 05:17
Exchange Announcement • 19 Dec 2024 21:30
Exchange Announcement • 06 Nov 2024 05:06
Exchange Announcement • 05 Nov 2024 08:00
Exchange Announcement • 07 Oct 2024 20:15
ENTITY
Ultragenyx Pharmaceutical (RARE US)
Ultragenyx Pharmaceutical (RARE US)
3
Analysis
Health Care • United States
Ultragenyx Pharmaceutical Inc. provides biotechnology services. The Company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.
more
x